Avid Bioservices, Inc. (CDMO) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 364 transactions totaling $14.5M, demonstrating a bearish sentiment with -$7.3M in net insider flow. The most recent transaction on Jul 15, 2024 involved a sale of 307 shares valued at $2.6K.
No significant insider buying has been recorded for CDMO in the recent period.
No significant insider selling has been recorded for CDMO in the recent period.
Based on recent SEC filings, insider sentiment for CDMO is bearish with an Insider Alignment Score of 25/100 and a net flow of -$7.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Avid Bioservices, Inc. (CDMO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading CDMO stock, having executed 364 transactions in the past 90 days. The most active insider is Mark R. Bamforth (Executive), who has made 5 transactions totaling $4.8M.
Get notified when executives and directors at CDMO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | R. Kwietniak Matthew | Executive | Sale | 307 | $8.36 | $2.6K | |
| Jul 15, 2024 | A. Richieri Richard | Executive | Sale | 530 | $8.36 | $4.4K | |
| Jul 12, 2024 | R. Kwietniak Matthew | Executive | Sale | 119 | $8.05 | $958 | |
| Jul 12, 2024 | R. Kwietniak Matthew | Executive | Option Exercise | 881 | $N/A | $0 | |
| Jul 12, 2024 | A. Richieri Richard | Executive | Option Exercise | 1,469 | $N/A | $0 | |
| Jul 11, 2024 | A. Richieri Richard | Executive | Sale | 59 | $7.54 | $445 | |
| Jul 11, 2024 | A. Richieri Richard | Executive | Sale | 1,456 | $7.54 | $11.0K | |
| Jul 11, 2024 | R. Kwietniak Matthew | Executive | Option Exercise | 335 | $N/A | $0 | |
| Jul 10, 2024 | Stewart Green Nicholas | Executive | Sale | 7,657 | $7.54 | $57.7K | |
| Jul 10, 2024 | R. Kwietniak Matthew | Executive | Sale | 444 | $7.54 | $3.3K | |
| Jul 10, 2024 | A. Richieri Richard | Executive | Sale | 910 | $7.54 | $6.9K | |
| Jul 10, 2024 | A. Richieri Richard | Executive | Sale | 115 | $7.54 | $867 | |
| Jul 10, 2024 | A. Richieri Richard | Executive | Option Exercise | 135 | $N/A | $0 | |
| Jul 10, 2024 | A. Richieri Richard | Executive | Option Exercise | 4,047 | $N/A | $0 | |
| Jul 9, 2024 | M. Alegria Esther | Executive | Option Exercise | 689 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 125 | $10.9M | 69.4% |
Purchase(P) | 19 | $3.6M | 22.7% |
Exercise(M) | 188 | $960.2K | 6.1% |
Other(J) | 31 | $270.5K | 1.7% |
Payment(F) | 1 | $10.4K | 0.1% |
Insider selling pressure at Avid Bioservices, Inc. has increased, with 17 insiders executing 364 transactions across all time. Total sales of $10.9M significantly outpace purchases of $3.6M, resulting in a net outflow of $7.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.